Detalhe da pesquisa
1.
Transcriptomic Analysis Reveals the Inability of Recombinant AAV8 to Activate Human Monocyte-Derived Dendritic Cells.
Int J Mol Sci
; 24(13)2023 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445621
2.
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.
Breast Cancer Res Treat
; 177(2): 383-393, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172407
3.
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma.
Blood
; 129(25): 3294-3303, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28483761
4.
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.
J Autoimmun
; 88: 61-74, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054368
5.
De Novo Truncating Mutations in the Kinetochore-Microtubules Attachment Gene CHAMP1 Cause Syndromic Intellectual Disability.
Hum Mutat
; 37(4): 354-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26751395
6.
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Int J Gynecol Cancer
; 26(2): 255-60, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26745694
7.
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.
Breast Cancer Res Treat
; 154(2): 351-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26536871
8.
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma.
Leukemia
; 34(12): 3298-3309, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409691
9.
Induction of Human Trophoblast Stem Cells from Somatic Cells and Pluripotent Stem Cells.
Cell Rep
; 33(8): 108419, 2020 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238118
10.
Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma.
Blood Cancer J
; 9(4): 41, 2019 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926770
11.
Genetic Association Analyses Highlight IL6, ALPL, and NAV1 As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis.
Circ Genom Precis Med
; 12(10): e002617, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32141789
12.
Parallel derivation of isogenic human primed and naive induced pluripotent stem cells.
Nat Commun
; 9(1): 360, 2018 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367672
13.
Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology.
Front Immunol
; 8: 547, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28579987
14.
Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells.
JCI Insight
; 2(3): e90088, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28194440
15.
Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/- Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice.
Front Immunol
; 8: 2014, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29445370
16.
Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I.
Int J Cardiol
; 207: 349-58, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26820365
17.
Search for Rare Copy-Number Variants in Congenital Heart Defects Identifies Novel Candidate Genes and a Potential Role for FOXC1 in Patients With Coarctation of the Aorta.
Circ Cardiovasc Genet
; 9(1): 86-94, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643481
18.
A consistent arrhythmogenic trait in Brugada syndrome cellular phenotype.
Clin Transl Med
; 11(6): e413, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34185406
19.
Fine-scale human genetic structure in Western France.
Eur J Hum Genet
; 23(6): 831-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25182131
20.
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
J Clin Oncol
; 32(34): 3840-7, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349301